Source
Published
The article discusses various updates in the field of 3D printing, including advancements in life sciences and quality management software. It covers a range of topics related to the latest developments and innovations in the industry.
The exclusive eBook delves into R3 Bio, a startup proposing brainless human clones as backup bodies for longevity. The startup's ethically charged vision raises concerns about cloning ethics. The eBook, available only to subscribers, explores the controversial pursuit of human longevity through cloning. Antonio Regalado's work sheds light on the startup's startling concept and its potential implications.
The article discusses recent developments in 3D printing technology, including the creation of support-free titanium structures, which could revolutionize manufacturing processes. Additionally, advancements in 3D printing are being utilized in drug delivery systems, allowing for more precise and customizable medication administration. These innovations highlight the expanding applications of 3D printing across various industries, showcasing its potential for future growth and impact.
Intel has seen improved revenue per wafer by reducing yield variability across each wafer, resulting in more sellable CPUs. The company's focus on tightening yield distribution across the wafer edges has led to increased margins and productivity. By implementing edge-specific process correction methods, Intel can extract more high-quality and sellable dies from a single wafer. These improvements are node-independent and have been attributed to disciplined execution improvements under new manufacturing leadership. Intel's efforts have led to better output and demand for CPUs, with even lower-quality chips now being sold as viable products.
The article discusses various updates in the 3D printing industry, including competition winners, a new AI platform, the X2D printer, and more. Unfortunately, due to the formatting of the content provided, it seems that the actual details of these updates are not accessible.
We use cookies to ensure you get the best experience on our website. For more information on how we use cookies, please see our cookie policy.